Company Overview and News

 
Trump’s Hard-Line Take on Trade Plays Into China’s Hands - Bloomberg

2018-03-08 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
India successfully test fires N-capable indigenous Agni-V ballistic missile

2018-01-18 freepressjournal.in
Bhubaneswar : India on Thursday successfully test fired its indigenously developed intercontinental surface-to-surface nuclear-capable ballistic missile Agni-V – the most potent and with the longest range in the Agni series – that can reach targets as far as Beijing.

 
China's deliverymen face robot revolution as parcel demand soars

2017-11-10 channelnewsasia
BEIJING: At Beijing's sprawling Renmin University of China, two shiny new couriers dart through throngs of students to deliver parcels throughout the day.

 
Featured Company News - Praxair Announces Long-term Contract with Shanghai Huali Microelectronics for Supply of Gases

2017-10-17 accesswire
LONDON, UK / ACCESSWIRE / October 17, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Praxair, Inc. (NYSE: PX), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=PX. The Company announced on that it had entered into a long-term contract with Shanghai Huali Microelectronics Corp.

 
Made For Sleep releases a revolutionary new pillow on Kickstarter crowdfunding

2017-06-09 prnewswire
SYDNEY, June 8, 2017 /PRNewswire/ -- Made For Sleep releases a revolutionary new pillow on Kickstarter crowdfunding today.

 
Mission Ready Provides Update on Wild Things Integration

2017-05-05 asdnews
Mission Ready Services Inc. (“Mission Ready” or the “Company”) (TSX-V: MRS) is pleased to provide the following update – further to the news release dated March 9, 2017 announcing the acquisition of Wild Things, LLC (“Wild Things”) – on the Integration of Wild Things into the Company’s current operations.

 
Mission Ready Provides Update on Wild Things Integration

2017-05-04 marketwired
VANCOUVER, BC--(Marketwired - May 04, 2017) - Mission Ready Services Inc. ("Mission Ready" or the "Company") (TSX VENTURE: MRS) is pleased to provide the following update -- further to the news release dated March 9, 2017 announcing the acquisition of Wild Things, LLC ("Wild Things") -- on the Integration of Wild Things into the Company's current operations.

 
Inside @StateDept: Leaked Cable Provides Guidance For ‘America First’ Cost Savings Initiatives « Diplopundit

2017-04-02 diplopundit.net
Posted: 1:48 pm ET Updated: 9:27 pm ET: See Aww, @StateDept Sends Official Take Down Request For April Fools’ Day Cable Follow @Diplopundit

 
Be afraid: China is on the path to global technology dominance

2017-03-24 scmp
I have often jested that the main difference between the United States and China is not that one is capitalist and the other communist. Rather, it is that one is run by lawyers and the other by engineers.

 
At the Made in America Store, it's a challenge to keep the aisles full - LA Times

2017-03-11 latimes
The Made in America store is the brainchild of Mark Andol, 50, an energetic, mile-a-minute talker with silver-tinged waved-back hair and a wispy mustache. (Video by Carolyn Cole / Los Angeles Times)

 
Frog Fractions: inside the mind behind the world's strangest video game | Technology | The Guardian

2017-03-01 theguardian
Jim Crawford is a self-confessed dilettante who moves from project to project in the blink of an eye. How did he create the most anarchic video game ever made?

 
Non-Volatile Memory Market Worth 81.51 Billion USD by 2022

2017-02-21 prnewswire
According to the new research report "Non-Volatile Memory Market by Type (Flash (NAND, NOR), EEPROM, NVSRAM, Embedded, EPROM, 3D NAND, MRAM/STTMRAM, FRAM, RERAM/CBRAM, NVDIMM, PCM, 3D XPOINT, NRAM), End-User Industry, and Geography - Global Forecast to 2022", published by MarketsandMarkets, the market is expected to be worth USD 81.51 Billion by 2022, at a CAGR of 9.96% between 2016 and 2022.

 
The Sinocism China Newsletter 02.17.17-Xi Must Have Enjoyed Trump's Press Conference | The Sinocism China Newsletter

2017-02-17 sinocism
President Trump’s Thursday press conference (full transcript and video) must have posed some interesting translation and analytical challenges for American experts in the PRC. How do they explain Trump to Xi Jinping? What is Chinese for “cray cray”?

 
The Sinocism China Newsletter 02.17.17-Xi Must Have Enjoyed Trump's Press Conference | The Sinocism China Newsletter

2017-02-17 sinocism
President Trump’s Thursday press conference (full transcript and video) must have posed some interesting translation and analytical challenges for American experts in the PRC. How do they explain Trump to Xi Jinping? What is Chinese for “cray cray”?

 
Who's in I'm a Celebrity 2016? Line-up rumours, new spin-off show gossip and everything you need to know - Mirror Online

2016-10-05 mirror.co.uk
I'm a Celebrity is almost upon us and as the days grow closer, the line-up rumoured contestants starts to take shape.

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...